Authors:
HABERKORN U
BELLEMANN ME
GERLACH L
MORR I
TROJAN H
BRIX G
ALTMANN A
DOLL J
VANKAICK G
Citation: U. Haberkorn et al., UNCOUPLING OF 2-FLUORO-2-DEOXYGLUCOSE TRANSPORT AND PHOSPHORYLATION IN RAT HEPATOMA DURING GENE-THERAPY WITH HSV THYMIDINE KINASE, Gene therapy, 5(7), 1998, pp. 880-887
Authors:
HABERKORN U
KREMS B
GERLACH L
BACHERT P
MORR I
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., ASSESSMENT OF GLUCOSYLIFOSFAMIDE MUSTARD BIODISTRIBUTION IN RATS WITHPROSTATE ADENOCARCINOMAS BY MEANS OF IN-VIVO P-31 NMR AND IN-VITRO UPTAKE EXPERIMENTS, Magnetic resonance in medicine, 39(5), 1998, pp. 754-761
Authors:
BELLEMANN ME
HABERKORN U
GERLACH L
BRIX G
Citation: Me. Bellemann et al., PHARMACOKINETIC ANALYSIS IN HETEROGENEOUS TISSUES - IMPACT OF MODEL CONFIGURATION, The Journal of nuclear medicine, 39(5), 1998, pp. 756-756
Authors:
HABERKORN U
BELLEMANN ME
ALTMANN A
GERLACH L
MORR I
OBERDORFER F
BRIX G
DOLL J
BLATTER J
VANKAICK G
Citation: U. Haberkorn et al., PET 2-FLUORO-2-DEOXYGLUCOSE UPTAKE IN RAT PROSTATE ADENOCARCINOMA DURING CHEMOTHERAPY WITH GEMCITABINE, The Journal of nuclear medicine, 38(8), 1997, pp. 1215-1221
Authors:
HABERKORN U
BELLEMANN ME
MORR I
GERLACH L
OBERDORFER F
BRIX G
DOLL J
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., CHANGES IN FDG UPTAKE AFTER THERAPY OF RAT PROSTATE ADENOCARCINOMAS WITH GLUCOSYLIFOSFAMIDE, The Journal of nuclear medicine, 38(5), 1997, pp. 1052-1052
Authors:
HABERKORN U
BELLEMANN ME
GERLACH L
MORR I
OBERDORFER F
TROJAN H
DOLL J
VANKAICK G
Citation: U. Haberkorn et al., PET STUDIES OF FDG UPTAKE DURING GENE-THERAPY WITH HSV THYMIDINE KINASE IN MORRIS HEPATOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 1053-1053
Authors:
LEVY L
MANDEVILLE JC
SIGUIER JM
REULET R
SARRAIL D
CATANI JP
GERLACH L
Citation: L. Levy et al., SIMULATION OF IN-FLIGHT ESD ANOMALIES TRIGGERED BY PHOTOEMISSION, MICROMETEOROID IMPACT AND PRESSURE PULSE, IEEE transactions on nuclear science, 44(6), 1997, pp. 2201-2208
Authors:
BRIX G
BELLEMANN ME
HABERKORN U
GERLACH L
LORENZ WJ
Citation: G. Brix et al., ASSESSMENT OF THE BIODISTRIBUTION AND METABOLISM OF 5-FLUOROURACIL ASMONITORED BY F-18 PET AND F-19 MRI - A COMPARATIVE ANIMAL STUDY, Nuclear medicine and biology, 23(7), 1996, pp. 897-906
Authors:
BRIX G
BELLEMANN ME
HABERKORN U
GERLACH L
LORENZ WJ
Citation: G. Brix et al., ASSESSMENT OF THE BIODISTRIBUTION AND METABOLISM OF 5-FLUOROURACIL ASMONITORED BY F-19 MRI AND F-18 PET - A COMPARATIVE ANIMAL STUDY, The Journal of nuclear medicine, 37(5), 1996, pp. 1116-1116
Authors:
HABERKORN U
KREMS B
GERLACH L
MORR I
BACHERT P
STRAUSS LG
DIMITRAKOPOULOUSTRAUSS A
WIESSLER M
VANKAICK G
Citation: U. Haberkorn et al., ASSESSMENT OF GLUCOSYLIFOSFAMIDE BIODISTRIBUTION IN RATS WITH PROSTATE ADENOCARCINOMA, The Journal of nuclear medicine, 37(5), 1996, pp. 1183-1183
Authors:
HABERKORN U
BELLEMANN ME
OBERDORFER F
MORR I
GERLACH L
BLATTER J
TROJAN H
DOLL J
VANKAICK G
Citation: U. Haberkorn et al., METABOLIC EFFECTS OF GEMCITABINE IN RAT PROSTATE ADENOCARCINOMAS, The Journal of nuclear medicine, 37(5), 1996, pp. 1188-1188
Authors:
BELLEMANN ME
HABERKORN U
BRIX G
GERLACH L
LORENZ WJ
Citation: Me. Bellemann et al., MEASUREMENT OF THE ARTERIAL INPUT FUNCTION AT HIGH TEMPORAL RESOLUTION IN DYNAMIC PET, The Journal of nuclear medicine, 37(5), 1996, pp. 1189-1189
Authors:
BRIX G
BELLEMANN ME
HABERKORN U
GERLACH L
BACHERT P
LORENZ WJ
Citation: G. Brix et al., MAPPING THE BIODISTRIBUTION AND CATABOLISM OF 5-FLUOROURACIL IN TUMOR-BEARING RATS BY CHEMICAL-SHIFT SELECTIVE F-19 MR-IMAGING, Magnetic resonance in medicine, 34(3), 1995, pp. 302-307
Authors:
VONKUMMER R
BERGER C
STINGELE R
GERLACH L
Citation: R. Vonkummer et al., DIFFERENT EFFECTS OF NITRIC-OXIDE SYNTHASE INHIBITION ON CEREBRAL BLOOD-FLOW RESPONSES TO HYPOXIC AND CARBON-MONOXIDE HYPOXIA, Stroke, 25(1), 1994, pp. 264-264